7Baggers

Blend Labs Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Cash and Cash Eq  
 Account Payables  
 Deferred Revenue  
20210630 20210930 20211231 20220331 20220630 20220930 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 052.82105.64158.45211.27264.09316.91369.73Milllion

Blend Labs Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 
                  
  assets                
  current assets:                
  cash and cash equivalents36,499,000 56,244,000 42,243,000 55,041,000 45,450,000 84,521,000 30,962,000 84,555,000 34,980,000 46,195,000 114,380,000 132,683,000 167,666,000 213,082,000 276,063,000 369,726,000 
  marketable securities and other investments51,801,000 48,574,000 56,233,000 61,744,000 67,153,000 43,504,000 105,960,000 160,406,000         
  trade and other receivables, net of allowance for credit losses of 99 and 50, respectively14,962,000                
  prepaid expenses and other current assets17,128,000 15,916,000 19,329,000 13,722,000 10,315,000 13,321,000 14,569,000 18,645,000 22,423,000 23,405,000 25,445,000 21,938,000 27,825,000 31,713,000 37,264,000 27,062,000 
  current assets held for sale from discontinued operations6,440,000 8,518,000               
  total current assets126,830,000 139,944,000 135,170,000 146,401,000 142,520,000 159,525,000 169,836,000 283,189,000 309,370,000 350,156,000 453,760,000 503,279,000 560,826,000 613,018,000 661,704,000 517,406,000 
  property and equipment21,179,000 16,993,000 12,321,000 9,723,000 7,617,000 5,984,000 3,945,000 4,451,000 4,973,000 5,408,000 6,037,000 6,239,000 5,895,000 6,155,000 8,412,000 8,596,000 
  operating lease right-of-use assets1,780,000 262,000 1,469,000 1,715,000 7,516,000 8,358,000 8,565,000 9,411,000 10,246,000 11,055,000 13,005,000 13,394,000 14,245,000 14,713,000 13,908,000 15,070,000 
  intangible assets73,000 77,000 2,081,000 2,085,000 2,099,000 2,103,000 2,108,000 2,114,000 2,119,000 2,123,000 2,131,000 13,136,000 168,935,000 173,008,000 189,785,000 194,175,000 
  deferred contract costs3,399,000 3,221,000 2,868,000 2,063,000 2,020,000 2,197,000 2,453,000 2,233,000 2,467,000 1,474,000 1,956,000 2,657,000 3,326,000 4,178,000 3,303,000 3,939,000 
  other non-current assets25,938,000 21,930,000 24,103,000 16,848,000 16,344,000 16,299,000 11,867,000 9,662,000 9,006,000 9,868,000 10,521,000 8,129,000 8,617,000 8,828,000 8,530,000 14,196,000 
  non-current assets held for sale from discontinued operations3,873,000 5,839,000               
  total assets183,072,000 188,266,000 178,012,000 186,129,000 185,410,000 201,760,000 206,065,000 318,354,000 350,496,000 385,442,000 492,768,000 599,324,000 1,054,430,000 1,112,486,000 1,178,226,000 1,043,537,000 
  liabilities, redeemable equity and stockholders’ equity                
  current liabilities:                
  accounts payable1,201,000 2,666,000 2,417,000 1,863,000 1,084,000 1,898,000 2,170,000 2,121,000 3,149,000 1,932,000 2,550,000 3,302,000 2,116,000 6,160,000 6,809,000 6,273,000 
  deferred revenue32,746,000 33,266,000 19,240,000 19,857,000 20,832,000 21,540,000 8,984,000 10,056,000 11,970,000 13,046,000 9,959,000 12,046,000 14,172,000 8,068,000 10,028,000 11,478,000 
  accrued compensation2,854,000 3,901,000 3,976,000 6,046,000 3,225,000 5,186,000 5,562,000 9,867,000 4,741,000 11,035,000 13,753,000 9,576,000 13,489,000 18,140,000 13,397,000 13,819,000 
  other current liabilities10,152,000 11,467,000 13,316,000 17,478,000 16,383,000 13,935,000 14,858,000 14,768,000 15,016,000 13,906,000 17,829,000 23,065,000 24,264,000 27,662,000 33,385,000 29,693,000 
  current liabilities held for sale from discontinued operations5,790,000 6,793,000               
  total current liabilities52,743,000 58,093,000 38,949,000 45,244,000 41,524,000 42,559,000 31,574,000 36,812,000 34,876,000 39,919,000 44,091,000 47,989,000 54,041,000 60,030,000 63,619,000 256,840,000 
  other non-current liabilities1,795,000 291,000 580,000 1,292,000 1,571,000 2,056,000 2,228,000 3,356,000 3,515,000 4,407,000 5,584,000 6,006,000 8,127,000 13,415,000 12,615,000  
  non-current liabilities held for sale from discontinued operations858,000 903,000               
  total liabilities55,396,000 59,287,000 40,330,000 47,491,000 48,267,000 189,867,000 179,118,000 267,308,000 265,867,000 272,068,000 277,720,000 281,882,000 290,379,000 301,895,000 302,985,000 510,818,000 
  commitments and contingencies                
  redeemable noncontrolling interest - held for sale from discontinued operations                
  series a redeemable convertible preferred stock, par value 0.00001 per share: 200,000 shares authorized as of june 30, 2025 and december 31, 2024, 150 shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively150,241,000                
  stockholders’ equity:                
  class a, class b and class c common stock, par value 0.00001 per share: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of june 30, 2025 and december 31, 2024; 260,051 (class a 256,424, class b 3,627, class c 0) and 258,173 (class a 254,426, class b 3,747, class c 0) shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively2,000                
  additional paid-in capital1,377,769,000 1,376,752,000 1,328,015,000 1,333,781,000 1,335,928,000 1,326,187,000 1,321,944,000 1,318,037,000 1,311,539,000 1,299,603,000 1,260,092,000 1,238,476,000 1,244,466,000 1,218,213,000 1,199,914,000 77,661,000 
  accumulated other comprehensive loss514,000 565,000 602,000 765,000 304,000 346,000  -402,000 -689,000 95,000 -2,160,000 -3,050,000 -2,625,000 -808,000 -88,000  
  accumulated deficit-1,400,850,000 -1,394,205,000 -1,384,975,000 -1,384,150,000 -1,381,705,000 -1,362,298,000 -1,341,630,000 -1,311,345,000 -1,269,585,000 -1,228,354,000 -1,082,368,000 -956,240,000 -514,869,000 -442,765,000 -371,078,000 -294,153,000 
  total stockholders’ equity-22,565,000 -16,886,000 -56,356,000 -49,602,000 -45,471,000 -35,763,000 -19,243,000 6,292,000 41,267,000 71,346,000 175,566,000 279,188,000 726,974,000 774,642,000 828,750,000 486,453,000 
  total liabilities, redeemable equity and stockholders’ equity183,072,000 188,266,000 178,012,000 186,129,000 185,410,000            
  trade and other receivables, net of allowance for credit losses of 102 and 50, respectively 10,692,000               
  series a redeemable convertible preferred stock, par value 0.00001 per share: 200,000 shares authorized as of march 31, 2025 and december 31, 2024, 150 shares issued and outstanding as of march 31, 2025 and december 31, 2024, respectively 145,865,000               
  class a, class b and class c common stock, par value 0.00001 per share: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of march 31, 2025 and december 31, 2024; 258,825 (class a 255,078, class b 3,747, class c 0) and 258,173 (class a 254,426, class b 3,747, class c 0) shares issued and outstanding as of march 31, 2025 and december 31, 2024, respectively 2,000               
  trade and other receivables, net of allowance for credit losses of 80 and 149, respectively  17,365,000              
  operating lease liabilities, non-current  801,000 955,000 5,172,000 6,398,000 6,982,000 8,135,000 9,236,000 10,236,000 12,090,000 12,654,000 13,684,000 14,607,000 13,589,000 14,555,000 
  debt, non-current     138,854,000 138,334,000 219,005,000 218,240,000 217,506,000 215,955,000 215,233,000 214,527,000 213,843,000 213,162,000  
  redeemable noncontrolling interest  52,375,000 50,747,000 49,169,000 47,656,000 46,190,000 44,754,000 43,362,000 42,028,000 39,482,000 38,254,000 37,077,000 35,949,000 46,491,000 46,266,000 
  series a redeemable convertible preferred stock, par value 0.00001 per share: 200,000 shares authorized as of december 31, 2024 and 2023, 150 and 0 shares issued and outstanding as of december 31, 2024 and 2023, respectively  141,663,000              
  class a, class b and class c common stock, par value 0.00001 per share: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of december 31, 2024 and 2023; 258,173 (class a 254,426, class b 3,747, class c 0) and 249,910 (class a 240,262, class b 9,648, class c 0) shares issued and outstanding as of december 31, 2024 and 2023, respectively  2,000              
  trade and other receivables, net of allowance for credit losses of 76 and 149, respectively   15,894,000             
  restricted cash, non-current   7,294,000 7,294,000 7,294,000 7,291,000 7,294,000 12,315,000 5,358,000 5,358,000 5,358,000 5,358,000 5,358,000 5,607,000 5,357,000 
  series a redeemable convertible preferred stock, par value 0.00001 per share: 200,000 shares authorized as of september 30, 2024 and december 31, 2023, 150 and 0 shares issued and outstanding as of september 30, 2024 and december 31, 2023, respectively   137,493,000             
  class a, class b and class c common stock, par value 0.00001 per share: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of september 30, 2024 and december 31, 2023; 255,881 (class a 252,134, class b 3,747, class c 0) and 249,910 (class a 240,262, class b 9,648, class c 0) shares issued and outstanding as of september 30, 2024 and december 31, 2023, respectively   2,000             
  trade and other receivables, net of allowance for credit losses of 91 and 149, respectively    19,602,000            
  series a redeemable convertible preferred stock, par value 0.00001 per share: 200,000 shares authorized, 150 and 0 shares issued and outstanding as of june 30, 2024 and december 31, 2023, respectively    133,445,000            
  class a, class b and class c common stock, par value 0.00001 per share: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 254,207 (class a 248,985, class b 5,222, class c 0) and 249,910 (class a 240,262, class b 9,648, class c 0) shares issued and outstanding as of june 30, 2024 and december 31, 2023, respectively    2,000            
  trade and other receivables, net of allowance for credit losses of 128 and 149, respectively     18,179,000           
  liabilities, redeemable noncontrolling interest and stockholders’ equity                
  preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of march 31, 2024 and december 31, 2023                
  class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 252,319 (class a 242,769, class b 9,550, class c 0) and 249,910 (class a 240,262, class b 9,648, class c 0) shares issued and outstanding as of march 31, 2024 and december 31, 2023, respectively     2,000           
  total liabilities, redeemable noncontrolling interest and stockholders’ equity     201,760,000 206,065,000 318,354,000 350,496,000 385,442,000 492,768,000 599,324,000 1,054,430,000 1,112,486,000 1,178,226,000 1,043,537,000 
  trade and other receivables, net of allowance for credit losses of 149 and 436, respectively      18,345,000          
  preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of december 31, 2023; no shares authorized, issued and outstanding as of december 31, 2022                
  class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of december 31, 2023; 249,910 (class a 240,262, class b 9,648, class c 0) and 240,931 (class a 230,210, class b 10,721, class c 0) shares issued and outstanding as of december 31, 2023 and december 31, 2022, respectively      2,000          
  accumulated other comprehensive gain      441,000          
  trade and other receivables, net of allowance for credit losses of 198 and 436, respectively       19,583,000         
  preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of september 30, 2023 and december 31, 2022                
  class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 247,946 (class a 238,045, class b 9,901, class c 0) and 240,931 (class a 230,210, class b 10,721, class c 0) shares issued and outstanding as of september 30, 2023 and december 31, 2022, respectively       2,000         
  marketable securities        230,618,000 260,662,000 286,397,000 317,812,000 331,714,000 334,147,000 317,491,000 83,959,000 
  trade and other receivables, net of allowance for credit losses of 171 and 436, respectively        21,349,000        
  preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of june 30, 2023 and december 31, 2022                
  class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 245,775 (class a 235,606, class b 10,169, class c 0) and 240,931 (class a 230,210, class b 10,721, class c 0) shares issued and outstanding as of june 30, 2023 and december 31, 2022, respectively        2,000        
  trade and other receivables, net of allowance for credit losses of 296 and 436, respectively         19,894,000       
  preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of march 31, 2023 and december 31, 2022                
  class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 243,607 (class a 233,056, class b 10,551, class c 0) and 240,931 (class a 230,210, class b 10,721, class c 0) shares issued and outstanding as of march 31, 2023 and december 31, 2022, respectively         2,000       
  trade and other receivables, net of allowance for credit losses of 670 and 1,371, respectively          27,538,000      
  goodwill           47,132,000 287,228,000 287,228,000 286,977,000 284,798,000 
  preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of september 30, 2022 and december 31, 2021                
  class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 237,577 (class a 224,944, class b 12,633, class c 0) and 230,324 (class a 217,691, class b 12,633, class c 0) shares issued and outstanding as of september 30, 2022 and december 31, 2021, respectively          2,000      
  trade and other receivables, net of allowance for credit losses of 1,376 and 1,371, respectively           30,846,000     
  preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of june 30, 2022 and december 31, 2021                
  class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 234,795 (class a 222,162, class b 12,633, class c 0) and 230,324 (class a 217,691, class b 12,633, class c 0) shares issued and outstanding as of june 30, 2022 and december 31, 2021, respectively           2,000     
  trade and other receivables, net of allowance for credit losses of 1,669 and 1,371, respectively            33,621,000    
  preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of march 31, 2022 and december 31, 2021                
  class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 232,400 (class a 219,767, class b 12,633, class c 0) and 230,324 (class a 217,691, class b 12,633, class c 0) shares issued and outstanding as of march 31, 2022 and december 31, 2021, respectively            2,000    
  trade and other receivables, net of allowance for credit losses of 1,371 and 0, respectively             34,076,000   
  restricted cash                
  founders convertible preferred stock and convertible preferred stock, 0.00001 par value: no shares authorized, issued and outstanding as of december 31, 2021; 128,123                
  preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of december 31, 2021; no shares authorized, issued and outstanding as of december 31, 2020.                
  class a, class, b and class c common stock, 0.00001 par value: 3,000,000             2,000 2,000  
  trade and other receivables              30,886,000 36,659,000 
  founders convertible preferred stock and convertible preferred stock, 0.00001 par value: no shares authorized, issued and outstanding as of september 30, 2021; 128,123                
  preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of september 30, 2021; no shares authorized, issued and outstanding as of december 31, 2020.                
  acquisition consideration payable               195,577,000 
  other long-term liabilities               14,423,000 
  acquisition consideration expected to be funded from long-term debt proceeds               225,000,000 
  founders convertible preferred stock, 0.00001 par value: 1,026,008 shares authorized as of june 30, 2021 and december 31, 2020; 691,666 and 1,026,007 shares issued and outstanding as of june 30, 2021 and december 31, 2020, respectively                
  convertible preferred stock, 0.00001 par value: 149,566,300 and 127,097,070 shares authorized as of june 30, 2021 and december 31, 2020, respectively; 146,180,902 and 121,352,684 shares issued and outstanding as of june 30, 2021 and december 31, 2020, respectively; aggregate liquidation preference of 710,477 and 387,841 as of june 30, 2021 and december 31, 2020, respectively               702,940,000 
  class a common stock                
  class b common stock               1,000 
  accumulated other comprehensive income               4,000 

We provide you with 20 years of balance sheets for Blend Labs stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Blend Labs. Explore the full financial landscape of Blend Labs stock with our expertly curated balance sheets.

The information provided in this report about Blend Labs stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.